Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical oral pilocarpine drops for xerostomia in adults with life-limiting illness or frailty
NL-OMON60736Phase 3Completed
- Sponsor
- Maastricht University Medical Center+
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in xerostomia comparing Pilocarpine hydrochloride with Placebo (2 arms). Primary endpoint: Responder rate at week 4. Started Apr 2023; status: completed.
02
Drugs
pilocarpine
03
Conditions
xerostomia
Beyond the preview
Go deeper on NL-OMON60736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60736.